Trial of semaglutide ends early based on successful demonstration of efficacy in sustaining kidney function in people with diabetes and kidney disease
Trial of semaglutide ends early based on successful demonstration of efficacy in sustaining kidney function in people with diabetes and kidney disease
www.reuters.com
Novo Nordisk stops Ozempic kidney trial after early signs of success
